Literature DB >> 22307947

Application of microfluidic systems in management of head and neck squamous cell carcinoma.

Faiz Tanweer1, Victoria Louise Green, Nicholas David Stafford, John Greenman.   

Abstract

Microfluidics is an emerging multidisciplinary field that has the potential to provide solutions to many of the current challenges in managing head and neck squamous cell carcinoma (HNSCC). Treatment strategies for this disease are often complex and associated with significant morbidity and mortality; furthermore, prediction of response to treatment remains inaccurate. Microfluidic technology allows a small sample of tumor to be maintained alive ex vivo within a microenvironment that mimics the in vivo milieu; the response of this tumor biopsy to treatment regimens can subsequently be investigated. Microfluidics is the science and technology of systems that process or manipulate microliter to nanoliter volumes of fluids in purpose-built devices fabricated from glass or other biocompatible polymers. The technology also involves miniaturization and integration of various laboratory procedures into novel analysis devices. The purpose of this review is to provide an overview of microfluidic devices and discuss potential applications in HNSCC management.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22307947     DOI: 10.1002/hed.22906

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  Lab-on-a-chip workshop activities for secondary school students.

Authors:  Mohammad M N Esfahani; Mark D Tarn; Tahmina A Choudhury; Laura C Hewitt; Ashley J Mayo; Theodore A Rubin; Mathew R Waller; Martin G Christensen; Amy Dawson; Nicole Pamme
Journal:  Biomicrofluidics       Date:  2016-02-02       Impact factor: 2.800

2.  A patient tumour-on-a-chip system for personalised investigation of radiotherapy based treatment regimens.

Authors:  R Kennedy; D Kuvshinov; A Sdrolia; E Kuvshinova; K Hilton; S Crank; A W Beavis; V Green; J Greenman
Journal:  Sci Rep       Date:  2019-04-19       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.